Journals / ANKEM Dergisi / 2006 / Cilt: 20 - Sayı: 4

A case of Acinetobacter baumannii meningitis successfully treated with high dose ampicillin/sulbactam after failure with meropenem

Meropenem ile tedavi başarısızlığı sonrası ampisilin/sulbaktam ile başarılı bir şekilde tedavi edilen Acinetobacter baumannıı menenjitli bir olgu

Pages
236–238
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report a case of Acinetobacter baumannii meningitis which was unresponsive to meropenem treatment and was treated with high dose ampicillin/sulbactam, is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Multidrug resistant Acinetobacter spp. associated meningitis is associated with high morbidity and mortality.
📊
Key Findings & Data:Ampicillin/sulbactam combination is in vitro effective on Acinetobacter spp.
💡
Conclusion & Impact:In this report a case of Acinetobacter baumannii meningitis which was unresponsive to meropenem treatment and was treated with high dose ampicillin/sulbactam, is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tedavi sonucu · Tedavi başarısızlığı · Acinetobacter baumannii

Abstract

Multidrug resistant Acinetobacter spp. associated meningitis is associated with high morbidity and mortality. Ampicillin/sulbactam combination is in vitro effective on Acinetobacter spp. In this report a case of Acinetobacter baumannii meningitis which was unresponsive to meropenem treatment and was treated with high dose ampicillin/sulbactam, is presented.

Özet

Çoğul antibiyotik dirençli Acinetobacter spp. menenjitleri mortalite ve morbiditeye neden olabilmektedir. Sulbaktamın ampisilinli ve sefoperazonlu kombinasyonu Acinetobacter türlerine karşı in-vitro olarak etkilidir. Bu bildiride yüksek doz meropeneme yanıtsız olup yüksek doz ampisilin/sulbaktam ile tedavi edilen bir Acinetobacter baumannii menenjit olgusu sunulmuştur.

🔖

Cite This Article

SİPAHİ, O. R., PULLUKÇU, H., TAŞBAKAN, M., YAMAZHAN, T., ARDA, B., DALBASTI, T., TURHAN, T., AYDEMİR, Ş., ULUSOY, S. (2006). A case of Acinetobacter baumannii meningitis successfully treated with high dose ampicillin/sulbactam after failure with meropenem. ANKEM Dergisi, Cilt: 20 - Sayı: 4, 236–238. https://ajindex.com/articles/204045

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Azap OK, Arslan H, Ergin F, İnci EK, Yapar G: Kolistinin non-fermentatif gram-negatif bakterilere in-vitro etkinliğinin değerlendirilmesi, Ankara Üniv Tıp Fak Mecm 2005;58(2):65-7
  2. Buke C, Sipahi OR, Yurtseven T, Zileli M: High dose of intrathecal netilmicin in the treatment of nosocomial Acinetobacter baumannii meningitis, J Infect 2005;51(5):420-2
  3. Kendirli T, Aydin HI, Hacihamdioglu D et al: Meningitis with multidrugresistant Acinetobacter baumannii treated with ampicillin/sulbactam, J Hosp Infect 2004;56(4):328
  4. Metan G, Alp E, Aygen B, Sumerkan B: Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis, Int J Antimicrob Agents 2006;Nov 27 [Epub ahead of print]
  5. Motaouakkil S, Charra B, Hachimi A et al: Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii, J Infect 2006;53(4):274-8
  6. Rodriguez Guardado A, Maradona JA, Asensi V et al: Postsurgical meningitis caused by Acinetobacter baumannii: study of 22 cases and review of the literature, Rev Clin Esp 2001;201(9):497-500
  7. Sacar S, Turgut H, Toprak S et al: A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4- year period, BMC Infect Dis 2006;6(Mar 8):43
  8. Tasbakan MI, Sipahi OR, Pullukcu H ve ark: Nöroşirürji Yoğun Bakım Ünitesi'nde görülen infeksiyonların değerlendirilmesi, Ege Tıp Derg 2006;45(2):127-30
  9. Wang FD, Lin ML, Lee WS, Liu CY: In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria, Int J Antimicrob Agents 2004;23(6):590-5.